These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55 related articles for article (PubMed ID: 13404111)
41. Is the use of fullerene in photodynamic therapy effective for atherosclerosis? Nitta N; Seko A; Sonoda A; Ohta S; Tanaka T; Takahashi M; Murata K; Takemura S; Sakamoto T; Tabata Y Cardiovasc Intervent Radiol; 2008; 31(2):359-66. PubMed ID: 18040738 [TBL] [Abstract][Full Text] [Related]
42. Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis. van Puijvelde GH; van Es T; van Wanrooij EJ; Habets KL; de Vos P; van der Zee R; van Eden W; van Berkel TJ; Kuiper J Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2677-83. PubMed ID: 17901374 [TBL] [Abstract][Full Text] [Related]
43. The selective peroxisomal proliferator-activated receptor-gamma agonist has an additive effect on plaque regression in combination with simvastatin in experimental atherosclerosis: in vivo study by high-resolution magnetic resonance imaging. Corti R; Osende JI; Fallon JT; Fuster V; Mizsei G; Jneid H; Wright SD; Chaplin WF; Badimon JJ J Am Coll Cardiol; 2004 Feb; 43(3):464-73. PubMed ID: 15013132 [TBL] [Abstract][Full Text] [Related]
44. CD40 and its ligand in atherosclerosis. Lutgens E; Lievens D; Beckers L; Donners M; Daemen M Trends Cardiovasc Med; 2007 May; 17(4):118-23. PubMed ID: 17482093 [TBL] [Abstract][Full Text] [Related]
45. [Experimental induction of atherosclerosis in the rabbit]. NARPOZZI A Boll Soc Ital Biol Sper; 1956; 32(7-8):710-2. PubMed ID: 13404111 [No Abstract] [Full Text] [Related]